A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma
Clinical trial NCT03422445 · UNKNOWN
Trial details
- NCT number
- NCT03422445
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-08
- Primary completion
- 2019-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.